General Information of the Compound
| Compound ID |
CP0384267
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(E)-N-[(1R,2S,5S,6R,14S)-6-[benzenesulfonyl(cyclopropylmethyl)amino]-5-hydroxy-11-methoxy-15-oxatetracyclo[10.2.1.05,14.08,13]pentadeca-8(13),9,11-trien-2-yl]-3-(furan-3-yl)-N-methylprop-2-enamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C33H36N2O7S
|
||||||||||||||||||
| Molecular Weight |
604.725
|
||||||||||||||||||
| Canonical SMILES |
COc1ccc2C[C@@H](N(CC3CC3)S(=O)(=O)c3ccccc3)[C@]3(O)CC[C@@H]([C@@H]4Oc1c2[C@H]34)N(C)C(=O)\C=C\c1ccoc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C33H36N2O7S/c1-34(28(36)13-10-22-15-17-41-20-22)25-14-16-33(37)27(18-23-11-12-26(40-2)32-29(23)30(33)31(25)42-32)35(19-21-8-9-21)43(38,39)24-6-4-3-5-7-24/h3-7,10-13,15,17,20-21,25,27,30-31,37H,8-9,14,16,18-19H2,1-2H3/b13-10+/t25-,27+,30-,31-,33+/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
RPOAEJZHJXDZID-RNSSHWGUSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01132, Orexin receptor type 2
Protein ID: PT02001, Orexin/Hypocretin receptor type 1